Delivery Order SPE2DR25D2005-SPE2DR26FE7Y7
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $3,570.95 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price contract with an ultimate completion date of December 10, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured without a set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,862.43 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, issued as a firm fixed-price delivery order with no set-aside designation, is scheduled for ultimate completion by November 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement through...
- The Defense Logistics Agency awarded a $9,096.42 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract is classified as a firm fixed price delivery order with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order represents...
- The Defense Logistics Agency awarded a $8,744.03 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a completion date of December 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,722.40 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, awarded on December 9, 2025, with completion scheduled for December 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,834.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded on August 15, 2025, with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on December 9, 2025, with completion scheduled for December 10, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $10,185.62. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is expected to be completed by November 19, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,819.08 and an ultimate completion date of December 5, 2025. This is a firm fixed price delivery order issued without any set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...